IGF1R and hepatocellular carcinoma: Ngo et al. reported that the expression of insulin-like growth factor-1 (IGF1R) is upregulated in sorafenib-resistant HCC cells and that IGF1R activation causes the nuclear translocation of Yes-associated protein followed by the induction of sorafenib resistance [33].